billHR7478Event Tuesday, February 10, 2026Analyzed

Patient Debt Relief Act

Bearish

Summary

The Patient Debt Relief Act (HR7478) imposes new Medicare compliance costs on hospital operators without providing offsetting reimbursement benefits. For-profit chains HCA and UHS are directly exposed. The bill is early-stage, but both stocks have already declined significantly over the trailing 30 days as the market prices in the regulatory overhang.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR7478 imposes Medicare compliance costs and collection restrictions on hospitals with zero offsetting benefits for for-profits
  • 2.HCA and UHS have already declined 9.2% and 6% respectively in the trailing 30 days as the market prices this risk
  • 3.Bill is early-stage (referred to committee) with low near-term passage probability, but regulatory overhang may persist

Market Implications

The market is correctly discounting HCA and UHS on this regulatory threat. HCA at $429.70 is near its 52-week low of $330; UHS at $168.24 is near $152.33. Both have further downside if the bill gains committee momentum, but also have a potential catalyst for recovery if the bill dies in committee—a likely scenario given the divided Congress. Investors should monitor committee assignments and hearing schedules for Energy & Commerce and Ways & Means.

Full Analysis

  1. WHAT HAPPENED: HR7478 was introduced February 10, 2026 by Rep. Vasquez (D-NM) with 18 cosponsors, all Democrats. The bill was referred to both the Energy and Commerce Committee and Ways and Means Committee. It has had no subsequent actions—it is early-stage with a long legislative path ahead. 2) MONEY TRAIL: The bill does not authorize or appropriate any new funding. It imposes new regulatory conditions on hospitals that participate in Medicare, with civil monetary penalties up to $1 million per noncompliance instance. The grant program for medical debt relief is authorized but not funded—a separate appropriations bill would be needed. 3) STRUCTURAL WINNERS AND LOSERS: For-profit hospital chains HCA and UHS are the clearest losers. They operate large portfolios of Medicare-dependent hospitals and lack the charitable mission offsets that not-for-profit and public hospitals can claim. Not-for-profit systems like HCA's competitors may face lower net compliance costs due to existing charity care infrastructure. 4) MARKET DATA: Real data confirms the bearish read. HCA fell from $488 on April 17 to $429.70 on April 30—a 9.2% decline. UHS fell from $182.41 to $168.24—a 6% decline. Both are now near their 52-week lows. The selloff accelerated after April 24, suggesting growing market recognition of the bill's potential impact despite its early stage. 5) TIMELINE: The bill faces hearings, markups, floor votes in both chambers, and potential signing. Given unified Democratic sponsorship and a Republican-controlled House, near-term passage is highly unlikely. However, regulatory risk will persist through the 119th Congress, creating continued overhang.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$HCA▼ Bearish
Est. $20.0M$100.0M revenue impact

What the bill does

New Medicare conditions of participation requiring hospitals to adopt specific financial assistance and medical debt collection standards, with civil monetary penalties up to $1,000,000 per instance of noncompliance, effective January 1, 2028.

Who must act

All hospitals participating in the Medicare program, including for-profit hospital chains such as HCA Healthcare.

What happens

Imposes compliance costs for implementing new financial assistance policies, debt collection restrictions, and administrative systems, with penalty exposure of up to $1M per violation, without providing any offsetting reimbursement increases or benefits to for-profit operators.

Stock impact

HCA operates 186 hospitals heavily reliant on Medicare reimbursement. New compliance mandates increase operating costs and legal risk without revenue offsets, compressing margins on a significant portion of its patient volume. HCA's 30-day decline of 9.2% (current $429.7) reflects market pricing of this regulatory burden.

$$UHS▼ Bearish
Est. $10.0M$50.0M revenue impact

What the bill does

Same as above: new Medicare conditions of participation with financial assistance and debt collection standards, and penalties up to $1M per violation.

Who must act

All Medicare-participating hospitals, including Universal Health Services' acute care and behavioral health facilities.

What happens

Imposes cost increases for compliance systems, legal risk from penalty exposure, and potential revenue disruption from constrained debt collection practices on Medicare patients, with no compensatory benefit in the bill.

Stock impact

UHS operates over 350 acute care and behavioral health facilities. Behavioral health facilities are highly dependent on government reimbursement. New debt collection restrictions could reduce cash collections on patient balances, while compliance costs add operational expense. 30-day decline of 6% (current $168.24) aligns with market recognition of this risk.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →